FORM 10-K

Company

Marker Therapeutics, Inc.

Filed

May 8, 2009

Period of Report

December 31, 2008

Accession Number

0001424884-09-000033

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →